| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |